Dexcom has announced that the company has received CE Mark for its Dexcom G6 System for people with diabetes ages two years and up. “The Dexcom G6 represents the future of diabetes management. Not only does the product eliminate the need for fingersticks, but it also maintains the performance, connectivity and accuracy that the diabetes community has come to expect from Dexcom CGM,” said John Lister, Dexcom’s General Manage...

Dexcom has announced that the FDA has granted a De Novo request for the Dexcom G6 CGM System, the newest generation of CGM for people with diabetes ages 2 and up. The Dexcom G6 is indicated by the FDA for use as both a standalone CGM and for integration into automated insulin dosing (AID) systems. The powerful and revolutionary new Dexcom G6 is the first CGM to receive this classification by the FDA.